Parashar, D.; Geethadevi, A.; Mittal, S.; McAlarnen, L.A.; George, J.; Kadamberi, I.P.; Gupta, P.; Uyar, D.S.; Hopp, E.E.; Drendel, H.;
et al. Correction: Parashar et al. Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance. Cancers 2022, 14, 958. Cancers 2022, 14, 2443.
https://doi.org/10.3390/cancers14102443
AMA Style
Parashar D, Geethadevi A, Mittal S, McAlarnen LA, George J, Kadamberi IP, Gupta P, Uyar DS, Hopp EE, Drendel H,
et al. Correction: Parashar et al. Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance. Cancers 2022, 14, 958. Cancers. 2022; 14(10):2443.
https://doi.org/10.3390/cancers14102443
Chicago/Turabian Style
Parashar, Deepak, Anjali Geethadevi, Sonam Mittal, Lindsey A. McAlarnen, Jasmine George, Ishaque P. Kadamberi, Prachi Gupta, Denise S. Uyar, Elizabeth E. Hopp, Holli Drendel,
and et al. 2022. "Correction: Parashar et al. Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance. Cancers 2022, 14, 958" Cancers 14, no. 10: 2443.
https://doi.org/10.3390/cancers14102443
APA Style
Parashar, D., Geethadevi, A., Mittal, S., McAlarnen, L. A., George, J., Kadamberi, I. P., Gupta, P., Uyar, D. S., Hopp, E. E., Drendel, H., Bishop, E. A., Bradley, W. H., Bone, K. M., Rader, J. S., Pradeep, S., & Chaluvally-Raghavan, P.
(2022). Correction: Parashar et al. Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance. Cancers 2022, 14, 958. Cancers, 14(10), 2443.
https://doi.org/10.3390/cancers14102443
